+1 347 708 0418
The DTaP Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global DTaP Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global DTaP Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
DTaP Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Vaccine
Live Attenuated Vaccine
Market segment by Application can be divided into
Government Institution
Private Sector
Other
The key market players for global DTaP Vaccine market are listed below:
GlaxoSmithKline
Sanofi Pasteur, Ltd.
Merck
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe DTaP Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DTaP Vaccine, with price, sales, revenue and global market share of DTaP Vaccine from 2019 to 2021.
Chapter 3, the DTaP Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTaP Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and DTaP Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe DTaP Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 DTaP Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DTaP Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global DTaP Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global DTaP Vaccine Market Size & Forecast
1.4.1 Global DTaP Vaccine Sales in Value (2016-2026))
1.4.2 Global DTaP Vaccine Sales in Volume (2016-2026)
1.4.3 Global DTaP Vaccine Price by Type (2016-2026) & (US$/Dose)
1.5 Global DTaP Vaccine Production Capacity Analysis
1.5.1 Global DTaP Vaccine Total Production Capacity (2016-2026)
1.5.2 Global DTaP Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 DTaP Vaccine Market Drivers
1.6.2 DTaP Vaccine Market Restraints
1.6.3 DTaP Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline DTaP Vaccine Product and Services
2.1.4 GlaxoSmithKline DTaP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Sanofi Pasteur, Ltd.
2.2.1 Sanofi Pasteur, Ltd. Details
2.2.2 Sanofi Pasteur, Ltd. Major Business
2.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Product and Services
2.2.4 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck DTaP Vaccine Product and Services
2.3.4 Merck DTaP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 DTaP Vaccine Sales by Manufacturer
3.1 Global DTaP Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global DTaP Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in DTaP Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 DTaP Vaccine Manufacturer Market Share
3.4.2 Top 6 DTaP Vaccine Manufacturer Market Share
3.5 Global DTaP Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and DTaP Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global DTaP Vaccine Market Size by Region
4.1.1 Global DTaP Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global DTaP Vaccine Revenue by Region (2016-2026)
4.2 North America DTaP Vaccine Revenue (2016-2026)
4.3 Europe DTaP Vaccine Revenue (2016-2026)
4.4 Asia-Pacific DTaP Vaccine Revenue (2016-2026)
4.5 South America DTaP Vaccine Revenue (2016-2026)
4.6 Middle East and Africa DTaP Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global DTaP Vaccine Sales in Volume by Type (2016-2026)
5.2 Global DTaP Vaccine Revenue by Type (2016-2026)
5.3 Global DTaP Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global DTaP Vaccine Sales in Volume by Application (2016-2026)
6.2 Global DTaP Vaccine Revenue by Application (2016-2026)
6.3 Global DTaP Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America DTaP Vaccine Sales by Type (2016-2026)
7.2 North America DTaP Vaccine Sales by Application (2016-2026)
7.3 North America DTaP Vaccine Market Size by Country
7.3.1 North America DTaP Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America DTaP Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe DTaP Vaccine Sales by Type (2016-2026)
8.2 Europe DTaP Vaccine Sales by Application (2016-2026)
8.3 Europe DTaP Vaccine Market Size by Country
8.3.1 Europe DTaP Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe DTaP Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific DTaP Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific DTaP Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific DTaP Vaccine Market Size by Region
9.3.1 Asia-Pacific DTaP Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific DTaP Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America DTaP Vaccine Sales by Type (2016-2026)
10.2 South America DTaP Vaccine Sales by Application (2016-2026)
10.3 South America DTaP Vaccine Market Size by Country
10.3.1 South America DTaP Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America DTaP Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa DTaP Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa DTaP Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa DTaP Vaccine Market Size by Country
11.3.1 Middle East & Africa DTaP Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa DTaP Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 DTaP Vaccine Typical Distributors
12.3 DTaP Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global DTaP Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global DTaP Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline DTaP Vaccine Product and Services
Table 6. GlaxoSmithKline DTaP Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Pasteur, Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur, Ltd. Major Business
Table 9. Sanofi Pasteur, Ltd. DTaP Vaccine Product and Services
Table 10. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck DTaP Vaccine Product and Services
Table 14. Merck DTaP Vaccine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global DTaP Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 16. Global DTaP Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in DTaP Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global DTaP Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 19. Head Office and DTaP Vaccine Production Site of Key Manufacturer
Table 20. DTaP Vaccine New Entrant and Capacity Expansion Plans
Table 21. DTaP Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. Global DTaP Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 23. Global DTaP Vaccine Sales by Region (2021-2026) & (K Doses)
Table 24. Global DTaP Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 25. Global DTaP Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 26. Global DTaP Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 27. Global DTaP Vaccine Sales by Type (2021-2026) & (K Doses)
Table 28. Global DTaP Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 29. Global DTaP Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 30. Global DTaP Vaccine Price by Type (2016-2021e) & (US$/Dose)
Table 31. Global DTaP Vaccine Price by Type (2021-2026) & (US$/Dose)
Table 32. Global DTaP Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 33. Global DTaP Vaccine Sales by Application (2021-2026) & (K Doses)
Table 34. Global DTaP Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 35. Global DTaP Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 36. Global DTaP Vaccine Price by Application (2016-2021e) & (US$/Dose)
Table 37. Global DTaP Vaccine Price by Application (2021-2026) & (US$/Dose)
Table 38. North America DTaP Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 39. North America DTaP Vaccine Sales by Country (2021-2026) & (K Doses)
Table 40. North America DTaP Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 41. North America DTaP Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 42. North America DTaP Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 43. North America DTaP Vaccine Sales by Type (2021-2026) & (K Doses)
Table 44. North America DTaP Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 45. North America DTaP Vaccine Sales by Application (2021-2026) & (K Doses)
Table 46. Europe DTaP Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 47. Europe DTaP Vaccine Sales by Country (2021-2026) & (K Doses)
Table 48. Europe DTaP Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 49. Europe DTaP Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 50. Europe DTaP Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 51. Europe DTaP Vaccine Sales by Type (2021-2026) & (K Doses)
Table 52. Europe DTaP Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 53. Europe DTaP Vaccine Sales by Application (2021-2026) & (K Doses)
Table 54. Asia-Pacific DTaP Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 55. Asia-Pacific DTaP Vaccine Sales by Region (2021-2026) & (K Doses)
Table 56. Asia-Pacific DTaP Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 57. Asia-Pacific DTaP Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 58. Asia-Pacific DTaP Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 59. Asia-Pacific DTaP Vaccine Sales by Type (2021-2026) & (K Doses)
Table 60. Asia-Pacific DTaP Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 61. Asia-Pacific DTaP Vaccine Sales by Application (2021-2026) & (K Doses)
Table 62. South America DTaP Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 63. South America DTaP Vaccine Sales by Country (2021-2026) & (K Doses)
Table 64. South America DTaP Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 65. South America DTaP Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 66. South America DTaP Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 67. South America DTaP Vaccine Sales by Type (2021-2026) & (K Doses)
Table 68. South America DTaP Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 69. South America DTaP Vaccine Sales by Application (2021-2026) & (K Doses)
Table 70. Middle East & Africa DTaP Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 71. Middle East & Africa DTaP Vaccine Sales by Country (2021-2026) & (K Doses)
Table 72. Middle East & Africa DTaP Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 73. Middle East & Africa DTaP Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 74. Middle East & Africa DTaP Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 75. Middle East & Africa DTaP Vaccine Sales by Type (2021-2026) & (K Doses)
Table 76. Middle East & Africa DTaP Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 77. Middle East & Africa DTaP Vaccine Sales by Application (2021-2026) & (K Doses)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. DTaP Vaccine Typical Distributors
Table 81. DTaP Vaccine Typical Customers
List of Figures
Figure 1. DTaP Vaccine Picture
Figure 2. Global DTaP Vaccine Sales Market Share by Type in 2020
Figure 3. Inactivated Vaccine
Figure 4. Live Attenuated Vaccine
Figure 5. Global DTaP Vaccine Sales Market Share by Application in 2020
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global DTaP Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 10. Global DTaP Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global DTaP Vaccine Sales (2016-2026) & (K Doses)
Figure 12. Global DTaP Vaccine Price by Type (2016-2026) & (US$/Dose)
Figure 13. Global DTaP Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 14. Global DTaP Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. DTaP Vaccine Market Drivers
Figure 16. DTaP Vaccine Market Restraints
Figure 17. DTaP Vaccine Market Trends
Figure 18. Global DTaP Vaccine Sales Market Share by Manufacturer in 2020
Figure 19. Global DTaP Vaccine Revenue Market Share by Manufacturer in 2020
Figure 20. DTaP Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 DTaP Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 DTaP Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 23. Global DTaP Vaccine Sales Market Share by Region (2016-2026)
Figure 24. Global DTaP Vaccine Revenue Market Share by Region (2016-2026)
Figure 25. North America DTaP Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Europe DTaP Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific DTaP Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. South America DTaP Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa DTaP Vaccine Revenue (2016-2026) & (USD Million)
Figure 30. Global DTaP Vaccine Sales Market Share by Type (2016-2026)
Figure 31. Global DTaP Vaccine Revenue Market Share by Type (2016-2026)
Figure 32. Global DTaP Vaccine Price by Type (2016-2026) & (US$/Dose)
Figure 33. Global DTaP Vaccine Sales Market Share by Application (2016-2026)
Figure 34. Global DTaP Vaccine Revenue Market Share by Application (2016-2026)
Figure 35. Global DTaP Vaccine Price by Application (2016-2026) & (US$/Dose)
Figure 36. North America DTaP Vaccine Sales Market Share by Type (2016-2026)
Figure 37. North America DTaP Vaccine Sales Market Share by Application (2016-2026)
Figure 38. North America DTaP Vaccine Sales Market Share by Country (2016-2026)
Figure 39. North America DTaP Vaccine Revenue Market Share by Country (2016-2026)
Figure 40. United States DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe DTaP Vaccine Sales Market Share by Type (2016-2026)
Figure 44. Europe DTaP Vaccine Sales Market Share by Application (2016-2026)
Figure 45. Europe DTaP Vaccine Sales Market Share by Country (2016-2026)
Figure 46. Europe DTaP Vaccine Revenue Market Share by Country (2016-2026)
Figure 47. Germany DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific DTaP Vaccine Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific DTaP Vaccine Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific DTaP Vaccine Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific DTaP Vaccine Revenue Market Share by Region (2016-2026)
Figure 56. China DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America DTaP Vaccine Sales Market Share by Type (2016-2026)
Figure 63. South America DTaP Vaccine Sales Market Share by Application (2016-2026)
Figure 64. South America DTaP Vaccine Sales Market Share by Country (2016-2026)
Figure 65. South America DTaP Vaccine Revenue Market Share by Country (2016-2026)
Figure 66. Brazil DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa DTaP Vaccine Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa DTaP Vaccine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa DTaP Vaccine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa DTaP Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. Turkey DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa DTaP Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Buy
